(Q39593587)

13 September 2017

Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection (English)

1 reference

13 September 2017

1 reference

Tanguay S

1

1 reference

13 September 2017

Bégin LR

2

1 reference

13 September 2017

Elhilali MM

3

1 reference

13 September 2017

Behlouli H

4

1 reference

13 September 2017

Karakiewicz PI

5

1 reference

13 September 2017

Aprikian AG

6

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

13 September 2017

1 reference

13 September 2017

59

1 reference

13 September 2017

2

1 reference

13 September 2017

261-265

1 reference

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate: critical analysis of two different test populations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assays

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

Outcome of sextant biopsy according to gland volume

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

Measurement of complexed PSA improves specificity for early detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

Complexed prostate-specific antigen and its volume indexes in the detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

Clinical evaluation of serum prostate-specific antigen-alpha1-antichymotrypsin complex values in diagnosis of prostate cancer: a cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901497-2

7 January 2021

10.1016/S0090-4295(01)01497-2

Identifiers

DOI

1 reference

13 September 2017

1 reference